LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
SK-BR-3 Enzastaurin
0.04
uM
LJP5
72
hr
1476 4294 3694 1.1624 1.2706
SK-BR-3 PD173074
0.04
uM
LJP6
72
hr
1476 4309 3694 1.1665 1.2773
SK-BR-3 XL147
0.12
uM
LJP5
72
hr
1476 4313 3694 1.1676 1.2793
BT-20 Enzastaurin
3.33
uM
LJP5
72
hr
1657 6589 5505 1.1969 1.2817
Hs 578T Sorafenib
3.33
uM
LJP6
72
hr
929 3894 3228 1.2063 1.2897
SK-BR-3 SU11274
0.04
uM
LJP5
72
hr
1476 4337 3694 1.1741 1.2901
SK-BR-3 XL147
3.33
uM
LJP5
72
hr
1476 4341 3694 1.1751 1.2918
Hs 578T SB590885
1.11
uM
LJP5
72
hr
929 3899 3228 1.2079 1.2920
MCF7 PIK-93
0.37
uM
LJP5
72
hr
1235 5022 4156 1.2085 1.2967
Hs 578T SB590885
0.04
uM
LJP5
72
hr
929 3913 3228 1.2123 1.2981
Hs 578T Sorafenib
0.37
uM
LJP6
72
hr
929 3923 3228 1.2155 1.3026
Hs 578T SB590885
3.33
uM
LJP5
72
hr
929 3939 3228 1.2202 1.3093
BT-20 Enzastaurin
10.0
uM
LJP5
72
hr
1657 6867 5505 1.2473 1.3538
SK-BR-3 XL147
1.11
uM
LJP5
72
hr
1476 4479 3694 1.2127 1.3543
Hs 578T Sorafenib
1.11
uM
LJP6
72
hr
929 4060 3228 1.2579 1.3622